DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 2USV Private Limited
03 1Glenmark Life Sciences Limited
04 1Hetero Drugs Limited
05 1Indoco Remedies Limited
06 1Ipca Laboratories Limited
07 1MSN Life Sciences Private Limited
08 1Shandong Xinhua Pharmaceutical Co., Ltd.
01 9Glimepiride
01 1China
02 8India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-041
Start Marketing Date : 2003-11-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
NDC Package Code : 62147-0009
Start Marketing Date : 2009-09-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USV offers custom peptide synthesis ranging from gram to multi-gram to multi-kilogram quantities.
NDC Package Code : 62147-0300
Start Marketing Date : 2009-09-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-800
Start Marketing Date : 2004-08-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0010
Start Marketing Date : 1995-11-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14445-018
Start Marketing Date : 2009-01-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1151
Start Marketing Date : 2012-02-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72640-019
Start Marketing Date : 2021-03-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58624-0708
Start Marketing Date : 2024-05-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Glimepiride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glimepiride, including repackagers and relabelers. The FDA regulates Glimepiride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glimepiride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glimepiride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glimepiride supplier is an individual or a company that provides Glimepiride active pharmaceutical ingredient (API) or Glimepiride finished formulations upon request. The Glimepiride suppliers may include Glimepiride API manufacturers, exporters, distributors and traders.
click here to find a list of Glimepiride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glimepiride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Glimepiride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Glimepiride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Glimepiride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glimepiride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Glimepiride suppliers with NDC on PharmaCompass.
We have 8 companies offering Glimepiride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
